Annexon Inc. Hosts KOL Event Showcasing Vonaprument for Geographic Atrophy
Annexon, Inc. ANNX | 6.33 6.33 | -0.31% 0.00% Post |
Annexon Inc. will host an in-person and virtual key opinion leader (KOL) event in New York on Wednesday, March 18, 2026, at 2:00 PM ET, featuring presentations on dry age-related macular degeneration (AMD) with geographic atrophy (GA), the role of C1q, and updates on vonaprument, Annexon's neuroprotective C1q inhibitor. To register, click here.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annexon Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9655050-en) on February 17, 2026, and is solely responsible for the information contained therein.
